Trials in China usually recruit patients faster than in the west because of the country’s large pool of people who have not yet taken drugs for their condition and who are keen to participate in ...

Asian markets rose Thursday, tracking gains on Wall Street and following the US Postal Service's U-turn on a ban on parcels ...

Chinese biotechs are increasingly seeking deals with multinational companies, and those deal structures are getting more creative. The “newco” deal structure is getting a lot of attention, but the ...

Wednesday closed up +0.39%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.71%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.42%. March E-mini S&P futures (ESH25) rose by +0.42%, ...

Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in ...

AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue ...

Toyota is developing and making electric vehicles and EV batteries in China under a new partnership with the Shanghai ...

As China and the U.S. battle over tariffs, locked in a tussle that could result in a deal or a trade war between the world's ...

Toyota Motor raised its annual earnings guidance after posting higher third-quarter net profit and said it will establish an electric-vehicle unit in China, seeking to shore up its operations in the ...

Asian shares are trading mostly lower as markets mull the impact of tariffs being imposed by the United States and China.

Beijing hit back with its own tariffs and export restrictions after being subjected to levies by President Trump. Trade ...

China opened an antitrust probe against Google as part of a sweeping set of retaliatory measures targeting the US economy ...